Drugs such as Zl006 (5-(3,5-dichloro-2-hydroxybenzylamino)-2-hydroxybenzoic acid) which can inhibit the formation of the neuronal nitric oxide synthase-PSD-95 complex can play a neuroprotective role in stroke treatment [29, 30]. The gene discussed is DLG4; the disease is stroke disorder.